ResMed Inc. Common Stock (RMD) stock analysis
RMD · ResMed Inc. Common Stock
Latest recorded price: USD 238.19
Model-estimated fair value: USD 168.79. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Instruments & Supplies
At $238.19, RMD trades 41.1% above the model's base-case value of $168.79. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $133.50 in the conservative case and $209.66 in the optimistic case, with a valuation confidence score of 87/100. Fiscal 2026 figures: revenue growth 10.2%, free cash flow margin 29.2%, ROIC 27.9%. The model flags 1 risk signal for this company.